Endothelial cells in vivo form the interface between the vascular and interstitial compartments and are strategically located t o mediate vascular permeability and hemostasis. One mechanism endothelial cells use t o maintain a nonthrombogenic surface is t o polarize basement membrane constituents t o the basolateral cell surface. In the present study, w e began characterization of the mechanisms used by endothelial cells in the assembly of a subcellular fibronectin matrix. Immunofluorescence microscopy was used t o localize extracellular matrix fibronectin in endothelial cell cultures. In contrast t o preconfluent and newly confluent cultures, post-confluent cultures assembled a fibronectin matrix that was restricted t o the basolatera1 cell surface. To determine if endothelial cells polarize fibronectin secretion, Millicell culture inserts were used t o distinguish proteins secreted from apical and basal sur-IBRONECTINS ARE A class of glycoproteins (440 to F 500 Kd) found in a soluble form in plasma and in an insoluble form in tissue extracellular matrices.' Sequencing studies have shown fibronectin to be organized into discrete units of amino acid homologies, termed type I, 11, and 111.' Fibronectin synthesized by cultured cells may contain one or two additional type I11 homology units that are not detected in plasma-derived f i b r~n e c t i n .~.~ The different molecular forms of fibronectin arise from alternative splicing of a single gene t r a n~c r i p t .~ Fibronectin in tissues may function as an adhesive protein important in cell migration, tissue organization, and wound repair. In vivo, plasma-derived fibronectin has been shown to incorporate into Similarly, cultured fibroblasts assemble a fibronectin matrix composed of cell-derived and plasma (serum)-derived fibr~nectin.~.~ Fibroblasts bind exogenous fibronectin from culture serum by high affinity sites that recognize type I repeats within the amino-terminal region of the fibronectin molecule.lO," In contrast to other cells of mesenchymal origin, endothelial cells assemble a fibronectin-containing matrix that is polarized to the basolateral cell surface.'* Since extracellular matrix promotes platelet adhesion and a~tivation,'~ the adaptation of mechanism(s) to polarize extracellular matrix formation is essential for endothelial cells to maintain a nonthrombogenic surface.
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The purpose of the present study was to identify the mechanisms underlying the assembly of subendothelial fibronectin matrix. To determine if endothelial cells polarize fibronectin secretion, Millicell culture inserts (Millipore, Bedford, MA) were used to separate apically and basally secreted proteins. The results indicate that formation of subendothelial fibronectin matrix occurs as endothelial cells acquire the ability to polarize fibronectin secretion. Polarized fibronectin secretion and subcellular matrix accumulation correlate in time with a marked increase in the ability of the monolayer to function as a barrier to "'1-fibronectin transport from the apical to basal chamber of Millicell inserts. In addition, endothelial cells possess high affinity binding sites for exogenous fibronectin on the basolateral cell surface, but not on the apical surface. These sites are similar to the high faces. Preconfluent and newly confluent cultures secreted fibronectin equally into apical and basal media. In contrast, post-confluent endothelial cells secreted fibronectin preferentially into the basal chamber. The degree t o which fibronectin secretion was polarized varied with time in culture and with the ability of the monolayers t o act as a barrier t o the movement of 1261-fibronectin from the apical t o basal chamber. In addition, high affinity binding sites for exogenous '251-fibronectin were found t o be present on the basolateral. but not apical, surface of post-confluent endothelial monolayers. These results indicate that subendothelial matrix assembly correlates with polarized fibronectin secretion, culture confluence, and expression of high affinity binding sites for fibronectin on the basolateral cell surface. 0 1990 by The American Society of Hematology.
affinity binding sites that have been described previously on fibroblast cells." These sites, termed matrix assembly sites, are believed to mediate fibronectin matrix formation via interaction with the amino-terminal region of the fibronectin molecule. These data suggest that assembly of subendothial fibronectin matrix results from basolateral fibronectin secretion and localized fibronectin polymerization.
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were prepared in rabbits," and IgG was purified by DEAE cellulose chromatography.
Endothelial cells were seeded onto glass coverslips in 35 mm tissue culture plates at 200,000 cells per plate in DMEM supplemented with fibronectin-depleted 20% fetal bovine serum. Serum was depleted of fibronectin using gelatin sepharose chromatography, and depletion was verified using a quantitative dot-blot assay. At various times, coverslips were removed and stained by indirect immunofluorescence for fibronectin." Cells were either fixed with paraformaldehyde or with paraformaldehyde followed by acetone. Control studies using non-immune IgG and no primary antibody were also conducted. Samples were viewed using an Olympus inverted phase contrast microscope equipped for fluorescence microscopy.
Staining of cells grown on filters. Silver stain was used to monitor growth of endothelial cells on Millicell filters. Endothelial cells were rinsed once with 5% glucose in H,O and stained with 1 mL silver nitrate (0.4% AgNo,, 5% glucose in H,O) for 1 minute. Cells were rinsed with 5% glucose and incubated for 3 minutes in 2% KBr in H,O. Next, cells were rinsed with 5% glucose, and the filter-cell layer was cut from the Millicell insert and mounted on a slide. Cells were visualized and photographed with an Olympus inverted phase contrast microscope with an attached Olympus 35 mm camera.
Endothelial cells were seeded onto 30 mm Millicell HA culture plate inserts (Millipore, Bedford, MA) at 100,000 cells per filter. At various times after plating, growth medium was removed, and the filter-cell layer was rinsed with methionine and glutamine-free minimal essential medium (MEM; Flow Laboratories, McLean, VA). Cultures were then pulse-labeled with either 50 pCi 'SS-methionine (Translabel; ICN Radiochemicals, Irvine, CA) or 50 pCi "Se-methionine (Amersham, Arlington Heights, IL), added to the apical chamber in 1 mL methionine-free MEM. Basal chambers received 2 mL methionine-free MEM. After 1 hour, pulse medium was removed, and filters were rinsed with chase medium (MEM with 0.05% bovine serum albumin). Cultures were chased for 2 hours in 1 mL chase medium added to the apical chamber and 2 mL in the basal chamber. Fibronectin was then immunoprecipitated from apical and basal media as described below. To determine if fibronectin secreted into the apical chamber could pass into the basal chamber over the time course of the chase period, '"I-fibronectin was added to the apical chambers of cultures at various days post-seed, and the percent flux into the basal chamber over a 2-hour period was determined.
Immunoprecipitation. Aliquots representing equal proportions of the total medium in each compartment were immunoprecipitated (600 pL of basal medium and 300 pL of apical medium). To equalize the volumes, 300 pL of fresh chase medium was added to conditioned apical medium. All samples received 200 pL of precipitation buffer (20 mmol/L Tris pH 8.8,4% DOC, 2% NP-40,2 mmol/L EDTA, 2 mmol/L phenylmethylsulfonyfluoride [PMSF] . 2 mmol/L iodoacetic acid, 2 mmol/L N-ethylmaleimide) and 20 pL rabbit anti-bovine fibronectin IgG or non-immune IgG. The mixture was incubated overnight at 4°C on a rocking platform. Protein A sepharose CL-4B (Pharmacia LKB Biotechnology Inc, Piscataway, NJ) was then added (50 pL, approximately 10 mg), and the incubation was continued overnight. Immune complexes were pelleted in an Eppendorf microfuge, resuspended in wash buffer (20 mmol/L Tris pH 8.8, 0.5% DOC, 0.5% NP-40, 50 mmol/L NaCI, 2 mmol/L EDTA, 2 mmol/L PMSF) and centrifuged. The washing step was repeated four times. Pellets were resuspended in 125 pL reducing gel buffer and electrophoresed into 6% polyacrylamide gels, and proteins were visualized by autoradiography or fluorography. For fluorography, Fuji X-ray film was preflashed to an absorbance (As4,,) 0.1 to 0.2 units above unflashed film and exposed to samples at -8OOC. The fibronectin present in the apical and basal chambers was quantified Indirect immunofluorescence.
Fibronectin secretion.
using a Shimadzu CS9OOOU scanning densitometer (Kyoto, JaFibronectin and the 70 Kd amino-terminal fibronectin fragment were iodinated by the chloramine T method, as previously described.'" Specific activity of fibronectin and the 70 Kd amino-terminal fragment were approximately 2.18 x los Ci/mol. '*'I-fibronectin was added to the culture medium of fibroblast and endothelial cells, and incorporation into both detergent soluble (pool I) and detergent insoluble matrix (pool 11) pools were quantified as described previo~sly.~ To measure the binding of '*'I-fibronectin and lZ5I-70 Kd fibronectin fragment to the apical and basal surface of endothelial cells and fibroblasts, cells were grown to confluence (7 to 9 days post-seed) in Transwell culture inserts (Costar, Cambridge, MA). Growth medium was removed from cultures and binding medium (DMEM containing 0.2% bovine serum albumin) containing radiolabeled proteins (approximately 200,000 cpm/mL) was added to either the apical or basal chamber of the insert (1.5 mL to the apical chambers and 2.6 mL to the basal chambers). Binding studies were conducted in the presence or absence of excess unlabeled protein (300 gg/mL fibronectin or 75 pg/mL 70 Kd fragment) at 4°C for 1 hour. Radioactivity bound in the presence of excess unlabeled protein represented nonspecifically bound material. Apical and basal media were collected, and the cell-filter layer was rinsed four times with phosphate-buffered saline (PBS) and cut from the Transwell insert. Radioactivity in the cell layers was quantified using gamma scintillation. Specific binding was determined by subtracting nonspecific binding from total binding. Binding to Transwell filters in the absence of cells was also measured.
pan).
Binding of '251-Jibronectin to cells.
RESULTS
Immunfluorescence localization of matrix fibronectin. Endothelial cells in vivo reside on a basement membrane that is polarized to the basolateral surface of the endothelial cell layer. To show that endothelial cells assemble a polarized fibronectin matrix and to ascertain the time course of appearance of this matrix, fibronectin was visualized in preconfluent, newly confluent, and post-confluent cultures (Fig 1) . T o distinguish apical and basal fibronectin, cells were fixed in either paraformaldehyde or paraformaldehyde followed by acetone. Fibronectin is visible on the apical cell surface in preconfluent cultures ( Fig 1B) and newly confluent cultures (Fig 1E) . In post-confluent cultures (Fig lH) , fibronectin is no longer visible on the apical cell surface. Preconfluent ( Fig 1C) and newly confluent (Fig 1 F) cultures treated with acetone exhibit fibronectin in amounts similar to that which appears in non-acetone-treated cells. In contrast, post-confluent cultures treated with acetone exhibit an extensive fibronectin matrix (Fig 11) . HA culture inserts. In this culture system. the cells are grown on a nitrocellulose filter membrane, and the cell monolayer and filter separate an apical and basal chamber. Because the nitrocellulose filters preclude the ability to directly visualize the cells by phase contrast microscopy, silver nitrate was used to monitor the development of endothelial cell monolayers. This method produccd a cobblestone-like pattern in confluent cultures (Fig 2B) but not in preconfluent cultures (Fig 2A) . When the cells first covered the entire surface of the filter with a cobblestone pattern. cells were considered to be confluent.
Fibronectin secretion was monitored by metabolically labeling cells grown on filters and collecting media from apical and basal chambers. Fibronectin was then immunoprecipitated and visualized by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography (Fig 3) . No proteins were immunoprecipitated when nonimmune IgG was substituted for anti-fibronectin IgG (data not shown). Fibronectin was secreted equally into apical and basal chambers by newly confluent cultures. In contrast, post-confluent cultures distributed fibronectin preferentially into the basal chamber. Cells cultured for 13 days sccreted fibronectin cqually into both chambers. indicating that preferential basolateral secretion occurs transiently.
Characterization of endothelial monolayers as a function of time in culture. To characterize further the properties of endothelial monolayers, a series of experiments was conducted over a 13-day period (Table I) . Cultures were monitored for the ability to silver stain as a cobblestone monolayer and to polarize fibroncctin secretion. In all experiments. endothelial cells did not stain as a cobblestone monolayer until the fifth day in culture. This cobblcstone appearance was present in monolayers throughout the remain- der of the time course. Preconfluent and newly confluent endothelial cells secreted fibronectin equally into the apical and basal chambers. In contrast. post-confluent cultures secreted greater than 75% of recovered fibronectin into the basal medium. Monolayers cultured for more than I I days did not polarize fibronectin secretion. indicating that vectorial fibronectin secretion was transient.
As described in Materials and Methods. control experiments were conducted in parallel with fibronectin secretion studies to ensure that apically secreted fibronectin was not crossing the monolayer and entering the basal compartment (Fig 4) . In these experiments. '"I-fibronectin was added to the apical chamber of cultures. and the percent of the total radioactivity that entered the basal chamber over a 2-hour period was calculated and expressed as percent flux. In addition to providing a control for polarized secretion. the percent flux indicates the ability of the monolayer to function as a barrier to "'I-fibronectin. Pre-confluent cultures (days 2 to 4) provided the least barrier to "'I-fibronectin. A 50% decrease in "'I-fibronectin flux was observed when cultures became confluent (days 5 and 6). This was followed by a subsequent decrease in flux that occurred in monolayers cultured for 7 to I I days. In addition. these cultures polarized fibronectin secretion (Table I) lation in time between the ability of the endothelial cells to act as a barrier to '251-fibronectin flux and the ability to polarize fibronectin secretion. Cells cultured for 12 to 13 days failed to polarize fibronectin secretion, although these monolayers continued to provide a barrier to i251-fibronectin.
* S i g n i f i i t t y different
Incorporation of jibronectin into endothelial monolayers.
It has been shown that fibroblast cells bind exogenous fibronectin via high affinity binding sites for the aminoterminal region of fibronectin and incorporate exogenous fibronectin into detergent insoluble matrix." To test the ability of endothelial cells to bind exogenous fibronectin and incorporate it into matrix, 'Z51-fibronectin was added to monolayers of both fibroblasts and endothelial cells on plastic culture plates. Figure 5 shows a time course of Iz5I-fibronectin binding (pool I) and incorporation into detergent insoluble matrix (pool 11) by confluent cultures of endothelial cells (Fig 5A) and fibroblasts (Fig 5B) . Throughout the time course, endothelial cells failed to bind or incorporate the exogenous fibronectin into matrix (Fig 5A) . In contrast, the fibroblasts did bind exogenous fibronectin and transferred the fibronectin to a detergent insoluble pool (pool 11) defined as matrix (Fig 5B) . Experiments using either radiolabeled bovine fibronectin or preconfluent endothelial cells yielded similar results (data not shown).
In confluent cultures, the basolateral surface of the endothelial cell monolayer is not exposed when the cells are cultured on plastic. If binding sites for exogenous fibronectin are localized to the basolateral surface, exogenous Iz5I-fibronectin may not be able to access these sites. To circumvent this problem, endothelial and fibroblast cells were grown in Transwell culture inserts, and i251-fibronectin was added to either the apical or basal media in the presence or absence of excess unlabeled fibronectin (Fig 6 ) . In addition, specific binding of the amino-terminal 70 Kd fibronectin fragment was measured. Fibroblasts bound '251-fibronectin when the protein was added to either the apical or basal media. In contrast, specific binding to endothelial cells could be detected only when i251-fibronectin was added to the basal medium. Identical results were obtained when the 70 Kd amino-terminal fibronectin fragment was used. i251-fibronectin binding to Transwell filters without cells was less than 0.5 x mol (data not shown). These results indicate that endothelial cells possess high affinity sites for fibronectin and that these sites are restricted to the basolateral cell surface. These sites are similar to the matrix assembly sites previously described on fibroblasts," which are believed to mediate fibronectin incorporation into matrix via the amino terminal portion of the fibronectin molecule.
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DISCUSSION
The results of the present study indicate that assembly of subendothelial matrix correlates in time with basolateral fibronectin secretion and the expression of high affinity fibronectin binding sites that are polarized to the basolateral cell surface. Extracellular matrix was localized to both the apical and basal surface in preconfluent and newly confluent cultures and these cultures did not polarize fibronectin secretion. In contrast, post-confluent cultures exhibited an extensive subcellular matrix and secreted fibronectin preferentially from the basolateral surface. High affinity binding sites believed to mediate fibronectin matrix assembly were distributed on the basolateral cell surface but not the apical surface.
The present study is the first report quantifying the polarized release of a constitutively secreted protein by endothelial cells. A recent study has shown the polarized release of von Willebrand factor from endothelial cell WeibelPalade bodies; however, constitutive secretion of von Willebrand factor was not polarized." The secretion of heparan sulfate proteoglycan and laminin was shown to be polarized by MDCK cells.19 The basolateral sorting of these basement membrane molecules was found to be dependent on the acidification of intracellular compartments. The proper routing of von Willebrand factor to Weibel-Palade bodies in endothelial cells has also been shown to be pH-dependent,20 although the polarized release of von Willebrand factor from Weibel-Palade bodies in response to secretagogues was pH-independent." Whether fibronectin secretion is pHdependent remains to be determined.
Polarized fibronectin secretion by the endothelial cells was found to be transient, appearing in post-confluent cultures between day 7 and day 11 after plating (see Table 1 ). The reason for the lack of polarized secretion after day 11 is not due to a deterioration of the barrier function of the monolayer. At this time, 1251-fibronectin flux is still low, indicating that the monolayer has remained intact and that fibronectin is not able to move freely from one chamber to the other (Fig  4) . The mechanism governing the depolarization of fibronectin secretion is not known, although this process may reflect a down-regulation of fibronectin matrix assembly.
In addition to vectorial fibronectin secretion, endothelial cells also polarized binding sites for fibronectin. Previous
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From studies on fibroblasts have shown the presence of high affinity binding sites for the amino-terminal region of fibronectin." These sites, termed matrix assembly sites, are believed to represent regions on the cell surface where fibronectin polymerizaton occurs.2' The results presented here indicate that these sites are also present on confluent endothelial cells, but are polarized to the basolateral cell surface. The localization of matrix assembly sites to the basolateral surface of endothelial cells may provide a mechanism to ensure that fibronectin polymerization is restricted to the basolateral cell surface. Fibronectin polymerization on the dorsal cell surface would be expected to disrupt the nonthrombogenic nature of the endothelium. Therefore, it is likely that the maintenance of this asymmetric matrix assembly process is tightly regulated.
These observations suggest that a series of changes occurs in the transition between newly confluent and post-confluent cultures. Previous studies indicate that plasma membrane proteins of cultured endothelial cell monolayers exhibit apicalbasal polarity.22 In addition, the formation of intercellular junctions would be expected after the cells form a confluent monolayer. It has been reported that endothelial monolayers cultured on amnion basement membrane develop increased electrical resistance over time in culture.23 Although the nature of endothelial junctions is unknown, the occurrence of close cell contacts would be consistent with the increased barrier function observed in post-confluent cultures as determined by '251-fibronectin flux. In cultured uterine epithelial cells, the formation of tight junctions is coincident with the establishment of both morphologic and functional polarity.24 However, it is unclear whether junction formation is antecedent to or results from the polarized phenotype of the cells.
The correlation in time between the appearance of a polarized fibronectin matrix and polarized fibronectin secretion suggests that basolateral fibronectin secretion contributes to the formation of a subcellular fibronectin matrix. In addition, the increased barrier function seen at the time of polarized fibronectin secretion indicates the presence of intercellular junctions or close cell contacts. These cell contacts may create a limited space for the distribution of basally secreted fibronectin. The simultaneous occurrence of these two events, in addition to the presence of basolateral high affinity binding sites for fibronectin, may potentiate fibronectin-fibronectin interactions at the basolateral cell surface, and thereby promote subcellular accumulation of fibronectin. Whether cell contacts are necessary for polarized fibronectin matrix assembly or result from the accumulation of subcellular fibronectin remains to be determined.
Using an in vivo would healing model, Clark et a125 showed that the fibronectin that accumulates in endothelial cell matrix during wound repair is cell-, rather than plasma-, derived. Recent studies using antibodies against the extra domain of fibronectin have localized cell-derived fibronectin to the basement membrane of large vessel endothelium. 26 It is interesting that the endothelial cells used in the present study are derived from a large vessel (pulmonary artery) and also accumulate cell-, but not plasma-(serum), derived fibronectin under normal culture conditions (unpublished observations). This is also demonstrated by the absence of accumulation of 'Z51-fibronectin in subendothelial matrix when cells were cultured on plastic dishes (Fig 5) . This fibronectin is presumably excluded from the basolateral surface of endothelial cells by intercellular contacts. Therefore, it may be a common trait of large vessel endothelial cells to produce an extensive endogenous fibronectin matrix. Alternatively, it is possible that culture conditions simulate a wound environment and induce the formation of a cellderived fibronectin matrix, as occurs during wound healing.
The exact role of fibronectin in the endothelial matrix in vitro and in vivo remains to be determined. Our results show a correlation between the accumulation of matrix fibronectin and increased barrier function of the endothelial monolayer. Fibronectin accumulation in the matrix may induce the formation of intercellular junctions and thereby increase the barrier function of the endothelial cell layer. Alternatively, the extensive fibronectin matrix may inhibit the flux of 1251-fibronectin. Although the primary role of fibronectin is thought to be cell attachment, endothelial cells in vitro are not dependent on fibronectin for adhe~ion.~' Clark et a12* demonstrated that fibronectin accumulation in endothelial matrix during wound healing correlates with endothelial cell proliferation and capillary ingrowth, suggesting a role for fibronectin in modulating the cells' state of proliferation and differentiation.
The results presented in this study indicate that subendothelial fibronectin matrix assembly correlates in time with polarized fibronectin secretion and with increased endothelial barrier function. Additionally, high affinity binding sites believed to be responsible for fibronectin matrix assembly were found to be restricted to the basolateral cell surface. Further studies are needed to determine what factors regulate subendothelial fibronectin deposition and to elucidate the role of this glycoprotein in endothelial cell function.
